By adopting a shape-persistent bimetallic design approach, high initial molecular turnover frequencies (up to 14,800 h(-1)) for coupling of CO2 with epoxides in conjunction with (n)Bu4NI, plus excellent yields under mild conditions (1 bar of CO2, 45 °C) have been achieved for catalysts containing cofacial Zn-salphen units.
A series
of conformationally rigid (Zn-salphen)2 complexes
with a planar bridging component (xanthene or dibenzofuran) are described.
Conformational changes for these assemblies are essentially limited
to the axial rotation of the Zn-salphen moieties; however, such geometric
constraints crucially permit the subtle tuning of the intermetallic
separation and geometry to potentially enhance catalytic activity
(and cooperative effects). The complexes have been investigated as
catalysts in conjunction with
n
Bu4NI for the coupling of CO2 with epoxides. Selected
dibenzofuran derivatives are significantly more active for the production
of cyclic carbonate than their mononuclear analogues under identical
conditions and concentrations of Zn sites. High initial turnover frequencies
(up to 29 000 h–1; 14 500 h–1 per Zn, using 10 bar of CO2 at 95 °C) and excellent
efficiencies under mild conditions (1 bar of CO2 at 55
°C) have been achieved. Kinetic studies using in situ (ReactIR)
spectroscopy and density functional theory calculations have been
performed, which reveal the existence of an intramolecular rate component
and a preference for the cooperative pathway as well as transition
states that depict the Zn sites operating in tandem. Taken together,
these results provide strong evidence of cooperative reactivity in
these Zn2 catalysts.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.